Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

NVCT

Nuvectis Pharma Inc

Dec 08 • 04:00PM ET

8.19

Dollar change -0.25
Percentage change -2.96	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Index	RUT	P/E	-	EPS (ttm)	-1.47	Insider Own	64.18%	Shs Outstand	14.64M	Perf Week	-2.62%
Market Cap	141.77M	Forward P/E	-	EPS next Y	-1.52	Insider Trans	2.05%	Shs Float	6.20M	Perf Month	-0.61%
Income	-22.33M	PEG	-	EPS next Q	-0.39	Inst Own	7.38%	Short Float / Ratio	5.57% / 7.87	Perf Quarter	-40.26%
Sales	0.00M	P/S	-	EPS this Y	5.83%	Inst Trans	29.42%	Short Interest	0.35M	Perf Half Y	-54.04%
Book/sh	0.96	P/B	8.50	EPS next Y	-7.03%	ROA	-94.78%	Target Price	20.67	Perf Year	7.20%
Cash/sh	1.27	P/C	6.43	EPS next 5Y	-	ROE	-120.53%	52W Range	7.14 - 18.65	Perf YTD	9.20%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-133.85%	52W High	-56.09%	Beta	0.19
Dividend %	-	Quick Ratio	3.99	Sales past 5Y	0.00%	Gross Margin	-	52W Low	14.71%	ATR	0.65
Employees	11	Current Ratio	3.99	Sales Q/Q	-	Oper. Margin	0.00%	RSI (14)	40.77	Volatility	5.32% 7.61%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	12.69%	Profit Margin	-	Rel Volume	1.13	Prev Close	8.44
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Nov 08 BMO	Payout	-	Avg Volume	43.90K	Price	8.19
Recom	1.00	SMA20	-0.87%	SMA50	-11.54%	SMA200	-38.16%	Volume	49,673	Change	-2.96%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-13-22	Initiated	Ladenburg Thalmann	Buy	$21

Nov-08-23 08:00AM	Nuvectis Pharma, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights (GlobeNewswire) -7.83%
Oct-24-23 08:00AM	Nuvectis Pharma Announces Upcoming Poster Presentation for NXP800 at the 2023 AACR Special Conference on Endometrial Cancer (GlobeNewswire)
Oct-16-23 09:35AM	Down -36.49% in 4 Weeks, Here's Why You Should You Buy the Dip in Nuvectis Pharma, Inc. (NVCT) (Zacks) +15.87%
Sep-25-23 07:30PM	Nuvectis Pharma Announces Updated Date and Time for the 2023 Cantor Global Healthcare Conference Corporate Presentation (GlobeNewswire)
Sep-21-23 08:00AM	Nuvectis Pharma Announces Upcoming Presentations for NXP800 and NXP900 (GlobeNewswire)
08:00AM	Loading…
Sep-12-23 08:00AM	Nuvectis Pharma Announces Initiation of the NXP900 Phase 1a Clinical Trial (GlobeNewswire)
Sep-06-23 08:00AM	Nuvectis Pharma to Host KOL Event to Discuss Its Two Precision Medicine Clinical-Stage Drug Candidates, NXP800 and NXP900 (GlobeNewswire)
Sep-01-23 08:00AM	Nuvectis Pharma Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Aug-17-23 08:00AM	Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA to NXP800 for the Treatment of Cholangiocarcinoma (GlobeNewswire)
Aug-11-23 07:01AM	Daily Vickers Top Insider Picks for 08/11/2023 (Argus Research)
Aug-10-23 06:24AM	Daily Vickers Top Insider Picks for 08/10/2023 (Argus Research)
Aug-09-23 08:00AM	Nuvectis Pharma, Inc. Reports Second Quarter 2023 Financial Results and Business Highlights (GlobeNewswire)
06:26AM	Daily Vickers Top Insider Picks for 08/09/2023 (Argus Research)
Aug-08-23 06:28AM	Daily Vickers Top Insider Picks for 08/08/2023 (Argus Research)
Aug-07-23 06:35AM	Daily Vickers Top Insider Picks for 08/07/2023 (Argus Research)
07:14AM	Loading…
Aug-04-23 07:14AM	Daily Vickers Top Insider Picks for 08/04/2023 (Argus Research)
Aug-03-23 07:15AM	Daily Vickers Top Insider Picks for 08/03/2023 (Argus Research)
Aug-02-23 07:52AM	Daily Vickers Top Insider Picks for 08/02/2023 (Argus Research) +7.41%
Aug-01-23 06:51AM	Daily Vickers Top Insider Picks for 08/01/2023 (Argus Research)
06:51AM	Daily Vickers Top Buyers & Sellers for 08/01/2023 (Argus Research)
Jul-31-23 06:44AM	Daily Vickers Top Insider Picks for 07/31/2023 (Argus Research)
Jul-28-23 07:58AM	Daily Vickers Top Insider Picks for 07/28/2023 (Argus Research)
07:58AM	Daily Vickers Top Buyers & Sellers for 07/28/2023 (Argus Research)
Jul-27-23 07:10AM	Daily Vickers Top Insider Picks for 07/27/2023 (Argus Research)
Jul-26-23 01:12PM	Daily Vickers Top Insider Picks for 07/26/2023 (Argus Research)
Jul-25-23 07:16AM	Daily Vickers Top Insider Picks for 07/25/2023 (Argus Research)
07:16AM	Daily Vickers Top Buyers & Sellers for 07/25/2023 (Argus Research)
Jul-24-23 07:12AM	Daily Vickers Top Insider Picks for 07/24/2023 (Argus Research)
Jul-21-23 07:23AM	Daily Vickers Top Insider Picks for 07/21/2023 (Argus Research) +5.18%
07:23AM	Daily Vickers Top Buyers & Sellers for 07/21/2023 (Argus Research)
06:55AM	Loading…
Jul-20-23 06:55AM	Daily Vickers Top Insider Picks for 07/20/2023 (Argus Research)
06:55AM	Daily Vickers Top Buyers & Sellers for 07/20/2023 (Argus Research)
Jul-19-23 07:10AM	Daily Vickers Top Insider Picks for 07/19/2023 (Argus Research)
07:10AM	Daily Vickers Top Buyers & Sellers for 07/19/2023 (Argus Research)
Jul-18-23 06:53AM	Daily Vickers Top Insider Picks for 07/18/2023 (Argus Research)
Jul-17-23 07:10AM	Daily Vickers Top Insider Picks for 07/17/2023 (Argus Research)
Jul-14-23 06:50AM	Daily Vickers Top Insider Picks for 07/14/2023 (Argus Research)
06:50AM	Daily Vickers Top Buyers & Sellers for 07/14/2023 (Argus Research)
Jul-13-23 07:02AM	Daily Vickers Top Insider Picks for 07/13/2023 (Argus Research)
07:02AM	Daily Vickers Top Buyers & Sellers for 07/13/2023 (Argus Research)
Jul-12-23 07:22AM	Daily Vickers Top Insider Picks for 07/12/2023 (Argus Research)
Jul-11-23 06:08AM	Daily Vickers Top Insider Picks for 07/11/2023 (Argus Research)
06:08AM	Daily Vickers Top Buyers & Sellers for 07/11/2023 (Argus Research)
Jul-10-23 06:56AM	Daily Vickers Top Insider Picks for 07/10/2023 (Argus Research) +5.97%
06:56AM	Daily Vickers Top Buyers & Sellers for 07/10/2023 (Argus Research)
Jul-05-23 06:46AM	Daily Vickers Top Insider Picks for 07/05/2023 (Argus Research)
Jul-03-23 06:50AM	Daily Vickers Top Insider Picks for 07/03/2023 (Argus Research)
Jun-30-23 06:52AM	Daily Vickers Top Insider Picks for 06/30/2023 (Argus Research)
Jun-29-23 06:49AM	Daily Vickers Top Insider Picks for 06/29/2023 (Argus Research)
Jun-28-23 07:13AM	Daily Vickers Top Buyers & Sellers for 06/28/2023 (Argus Research)
06:58AM	Daily Vickers Top Insider Picks for 06/28/2023 (Argus Research)
Jun-27-23 06:46AM	Daily Vickers Top Insider Picks for 06/27/2023 (Argus Research)
06:46AM	Daily Vickers Top Buyers & Sellers for 06/27/2023 (Argus Research)
Jun-26-23 06:41AM	Daily Vickers Top Buyers & Sellers for 06/26/2023 (Argus Research)
Jun-21-23 07:20AM	Daily Vickers Top Buyers & Sellers for 06/21/2023 (Argus Research)
Jun-20-23 08:00AM	Nuvectis Pharma Set to Join the Russell 2000® and Russell 3000® Indexes (GlobeNewswire)
06:35AM	Daily Vickers Top Buyers & Sellers for 06/20/2023 (Argus Research)
Jun-18-23 08:03AM	Charles Mosseri-Marlio Buys 1.3% More Nuvectis Pharma Shares \ (Simply Wall St.)
Jun-05-23 08:50AM	Here's Why Momentum in Nuvectis Pharma, Inc. (NVCT) Should Keep going (Zacks)
Jun-01-23 04:48AM	Zacks.com featured highlights Corsair Gaming, Nuvectis Pharma and WisdomTree (Zacks)
May-31-23 06:22AM	3 Best Breakout Stocks Worth Buying for Superlative Returns (Zacks)
May-19-23 08:50AM	Here's What Could Help Nuvectis Pharma, Inc. (NVCT) Maintain Its Recent Price Strength (Zacks)
May-15-23 09:55AM	Wall Street Analysts Think Nuvectis Pharma, Inc. (NVCT) Could Surge 29.35%: Read This Before Placing a Bet (Zacks) +6.19%
08:00AM	Nuvectis Pharma Announces FDA Clearance of NXP900 IND (GlobeNewswire)
May-10-23 08:00AM	Nuvectis Pharma, Inc. Reports First Quarter 2023 Financial Results and Business Highlights (GlobeNewswire)
May-09-23 01:34PM	We're Not Very Worried About Nuvectis Pharma's (NASDAQ:NVCT) Cash Burn Rate (Simply Wall St.)
May-02-23 06:46AM	Daily Vickers Top Insider Picks for 05/02/2023 (Argus Research) -5.07%
May-01-23 06:45AM	Daily Vickers Top Insider Picks for 05/01/2023 (Argus Research)
Apr-28-23 07:04AM	Daily Vickers Top Insider Picks for 04/28/2023 (Argus Research)
Apr-27-23 10:14AM	Correction: Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference (GlobeNewswire)
08:00AM	Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference (GlobeNewswire)
06:47AM	Daily Vickers Top Insider Picks for 04/27/2023 (Argus Research)
Apr-26-23 06:26AM	Daily Vickers Top Insider Picks for 04/26/2023 (Argus Research)
Apr-20-23 07:03AM	Daily Vickers Top Insider Picks for 04/20/2023 (Argus Research) -5.33%
Apr-19-23 06:53AM	Daily Vickers Top Insider Picks for 04/19/2023 (Argus Research)
Apr-18-23 08:00AM	Nuvectis Pharma Recaps Poster Presentation Highlights for NXP800's Activity in Cholangiocarcinoma PDX Models at the 2023 American Association for Cancer Research (AACR) Annual Meeting (GlobeNewswire)
Apr-17-23 06:54AM	Daily Vickers Top Insider Picks for 04/17/2023 (Argus Research)
Apr-14-23 06:37AM	Daily Vickers Top Insider Picks for 04/14/2023 (Argus Research)
Apr-13-23 06:52AM	Daily Vickers Top Insider Picks for 04/13/2023 (Argus Research)
Apr-12-23 07:07AM	Daily Vickers Top Insider Picks for 04/12/2023 (Argus Research)
Apr-11-23 06:58AM	Daily Vickers Top Insider Picks for 04/11/2023 (Argus Research) +9.57%
Apr-10-23 08:00AM	Nuvectis Pharma Announces Initiation of the Phase 1b Study for NXP800 in Platinum-Resistant, ARID1a-Mutated Ovarian Carcinoma (GlobeNewswire)
06:44AM	Daily Vickers Top Insider Picks for 04/10/2023 (Argus Research)
Apr-07-23 07:44AM	Daily Vickers Top Insider Picks for 04/07/2023 (Argus Research)
Apr-06-23 07:20AM	Daily Vickers Top Insider Picks for 04/06/2023 (Argus Research)
Apr-05-23 07:19AM	Nuvectis Pharma, Inc. (NASDAQ:NVCT) insiders have recently purchased stock and their bets paid off last week as company hit US$198m market cap (Simply Wall St.) -5.75%
06:11AM	Daily Vickers Top Insider Picks for 04/05/2023 (Argus Research)
Apr-04-23 07:08AM	Daily Vickers Top Insider Picks for 04/04/2023 (Argus Research)
Apr-03-23 06:48AM	Daily Vickers Top Insider Picks for 04/03/2023 (Argus Research)
Mar-31-23 06:36AM	Daily Vickers Top Insider Picks for 03/31/2023 (Argus Research) +5.47%
Mar-30-23 06:36AM	Daily Vickers Top Insider Picks for 03/30/2023 (Argus Research) +5.79%
Mar-29-23 06:32AM	Daily Vickers Top Insider Picks for 03/29/2023 (Argus Research)
Mar-17-23 08:00AM	Nuvectis Pharma Announces Upcoming Presentations at the 2023 American Association for Cancer Research Meeting (GlobeNewswire) +5.66%
Mar-10-23 08:00AM	Nuvectis Pharma to Participate in a Fireside Chat at the 35th Annual Roth Conference (GlobeNewswire) +7.73%
Mar-09-23 05:29AM	Bullish insiders bet US$1.1m on Nuvectis Pharma, Inc. (NASDAQ:NVCT) (Simply Wall St.) -9.58%
Mar-07-23 08:00AM	Nuvectis Pharma, Inc. Reports Fiscal Year 2022 Financial Results and Business Highlights (GlobeNewswire)
Feb-23-23 08:00AM	Nuvectis Pharma Recaps Poster Presentation Highlights for NXP800 at the 2023 ESMO Gynecological Cancers Congress (GlobeNewswire)
Feb-16-23 07:28AM	Daily Vickers Top Insider Picks for 02/16/2023 (Argus Research)
Feb-15-23 07:01AM	Daily Vickers Top Insider Picks for 02/15/2023 (Argus Research)
Feb-10-23 06:42AM	Daily Vickers Top Insider Picks for 02/10/2023 (Argus Research) +21.57%

Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BENTSUR RON	Chairman & CEO	Oct 10	Buy	11.08	640	7,091	3,237,484	Oct 12 04:05 PM
BENTSUR RON	Chairman & CEO	Oct 09	Buy	11.19	830	9,288	3,236,844	Oct 10 08:30 AM
BENTSUR RON	Chairman & CEO	Oct 06	Buy	11.27	250	2,818	3,236,014	Oct 10 08:30 AM
BENTSUR RON	Chairman & CEO	Oct 05	Buy	11.09	1,400	15,526	3,235,764	Oct 06 08:37 AM
BENTSUR RON	Chairman & CEO	Oct 04	Buy	10.95	1,820	19,929	3,234,364	Oct 06 08:37 AM
BENTSUR RON	Chairman & CEO	Aug 16	Buy	15.15	115	1,742	3,232,544	Aug 16 04:05 PM
BENTSUR RON	Chairman & CEO	Aug 15	Buy	14.34	235	3,370	3,232,429	Aug 16 04:05 PM
BENTSUR RON	Chairman & CEO	Aug 11	Buy	14.66	180	2,639	3,232,194	Aug 11 06:07 PM
BENTSUR RON	Chairman & CEO	Aug 08	Buy	14.83	120	1,780	3,232,014	Aug 11 06:07 PM
Mosseri Marlio Charles	10% Owner	Jul 31	Buy	13.88	860	11,937	2,595,000	Aug 01 08:00 AM
Mosseri Marlio Charles	10% Owner	Jul 28	Buy	13.91	2,584	35,943	2,594,140	Jul 31 08:00 AM
Mosseri Marlio Charles	10% Owner	Jul 27	Buy	13.98	1,556	21,753	2,591,556	Jul 28 08:00 AM
Mosseri Marlio Charles	10% Owner	Jul 26	Buy	13.97	10,000	139,700	2,590,000	Jul 27 06:52 AM
Mosseri Marlio Charles	10% Owner	Jul 21	Buy	14.61	2,844	41,551	2,580,000	Jul 24 04:45 PM
BENTSUR RON	Chairman & CEO	Jul 21	Buy	14.85	225	3,341	3,231,894	Jul 24 04:45 PM
Mosseri Marlio Charles	10% Owner	Jul 20	Buy	14.40	5,394	77,674	2,577,156	Jul 24 04:45 PM
BENTSUR RON	Chairman & CEO	Jul 20	Buy	15.06	110	1,657	3,231,669	Jul 24 04:45 PM
Mosseri Marlio Charles	10% Owner	Jul 19	Buy	14.84	8,000	118,720	2,571,762	Jul 20 06:30 AM
BENTSUR RON	Chairman & CEO	Jul 19	Buy	14.33	200	2,866	3,231,559	Jul 20 06:30 AM
Mosseri Marlio Charles	10% Owner	Jul 18	Buy	14.84	9,149	135,771	2,563,762	Jul 19 08:06 AM
BENTSUR RON	Chairman & CEO	Jul 14	Buy	15.03	150	2,254	3,231,359	Jul 18 08:34 AM
Mosseri Marlio Charles	10% Owner	Jul 12	Buy	15.09	3,285	49,571	2,554,613	Jul 13 08:30 AM
Mosseri Marlio Charles	10% Owner	Jul 11	Buy	15.36	10,000	153,600	2,551,328	Jul 12 08:30 AM
Mosseri Marlio Charles	10% Owner	Jul 07	Buy	15.19	8,948	135,920	2,541,328	Jul 10 08:00 AM
BENTSUR RON	Chairman & CEO	Jul 07	Buy	16.19	110	1,781	3,231,209	Jul 18 08:34 AM
Mosseri Marlio Charles	10% Owner	Jul 06	Buy	15.01	3,179	47,717	2,532,380	Jul 07 08:04 AM
BENTSUR RON	Chairman & CEO	Jul 06	Buy	14.88	320	4,762	3,231,099	Jul 07 08:03 AM
Mosseri Marlio Charles	10% Owner	Jul 05	Buy	15.52	1,176	18,252	2,529,201	Jul 06 07:45 AM
Mosseri Marlio Charles	10% Owner	Jun 26	Buy	16.46	16,760	275,870	2,528,025	Jun 27 08:45 AM
BENTSUR RON	Chairman & CEO	Jun 26	Buy	16.50	750	12,375	3,230,779	Jun 27 08:45 AM
Mosseri Marlio Charles	10% Owner	Jun 23	Buy	17.43	73,175	1,275,440	2,511,265	Jun 26 08:45 AM
Mosseri Marlio Charles	10% Owner	Jun 22	Buy	17.73	6,999	124,092	2,438,090	Jun 23 08:59 AM
Mosseri Marlio Charles	10% Owner	Jun 21	Buy	17.71	6,091	107,872	2,431,091	Jun 23 08:59 AM
BENTSUR RON	Chairman & CEO	Jun 21	Buy	17.88	500	8,940	3,230,029	Jun 22 08:42 AM
Mosseri Marlio Charles	10% Owner	Jun 16	Buy	17.75	12,700	225,425	2,425,000	Jun 20 08:25 AM
Mosseri Marlio Charles	10% Owner	Jun 15	Buy	17.71	32,124	568,848	2,412,300	Jun 16 06:46 AM
BENTSUR RON	Chairman & CEO	Jun 08	Buy	17.53	120	2,104	3,229,529	Jun 08 09:28 PM
BENTSUR RON	Chairman & CEO	Jun 07	Buy	17.41	230	4,004	3,229,409	Jun 08 09:28 PM
BENTSUR RON	Chairman & CEO	May 31	Buy	17.28	330	5,702	3,229,179	Jun 01 08:00 AM
BENTSUR RON	Chairman & CEO	May 24	Buy	17.49	200	3,498	3,228,849	May 26 09:29 AM
BENTSUR RON	Chairman & CEO	May 16	Buy	17.02	320	5,448	3,228,649	May 18 07:00 AM
Poradosu Enrique	Chief Science & Business Off	Mar 27	Buy	11.55	500	5,775	1,373,819	Mar 28 08:30 AM
BENTSUR RON	Chairman & CEO	Mar 23	Buy	12.13	230	2,790	3,228,329	Mar 27 08:21 AM
BENTSUR RON	Chairman & CEO	Mar 21	Buy	12.08	480	5,798	3,228,099	Mar 23 08:30 AM
Shemesh Shay	Chief Dev. & Ops. Officer	Mar 21	Buy	11.99	420	5,036	1,361,955	Mar 22 08:30 AM
Shemesh Shay	Chief Dev. & Ops. Officer	Mar 15	Buy	10.71	670	7,176	1,361,535	Mar 17 08:31 AM
BENTSUR RON	Chairman & CEO	Mar 15	Buy	10.91	480	5,237	3,227,619	Mar 16 04:45 PM
BENTSUR RON	Chairman & CEO	Mar 14	Buy	10.85	1,680	18,228	3,227,139	Mar 16 04:45 PM
Shemesh Shay	Chief Dev. & Ops. Officer	Dec 21	Buy	7.65	500	3,825	1,245,865	Dec 22 08:30 AM

Open in Screener

XAIR

Beyond Air Inc

Dec 08 • 04:00PM ET

1.47

Dollar change +0.02
Percentage change 1.38	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Index	RUT	P/E	-	EPS (ttm)	-2.04	Insider Own	19.49%	Shs Outstand	30.74M	Perf Week	-11.75%
Market Cap	46.84M	Forward P/E	-	EPS next Y	-1.77	Insider Trans	6.02%	Shs Float	25.74M	Perf Month	-26.75%
Income	-63.23M	PEG	-	EPS next Q	-0.53	Inst Own	29.24%	Short Float / Ratio	10.83% / 8.35	Perf Quarter	-53.64%
Sales	0.30M	P/S	156.12	EPS this Y	-9.23%	Inst Trans	15.75%	Short Interest	2.79M	Perf Half Y	-75.15%
Book/sh	0.81	P/B	1.82	EPS next Y	12.96%	ROA	-57.00%	Target Price	12.00	Perf Year	-74.91%
Cash/sh	1.37	P/C	1.07	EPS next 5Y	-	ROE	-92.56%	52W Range	1.17 - 7.74	Perf YTD	-77.43%
Dividend	-	P/FCF	-	EPS past 5Y	9.16%	ROI	-150.99%	52W High	-81.07%	Beta	-0.23
Dividend %	-	Quick Ratio	3.66	Sales past 5Y	-43.84%	Gross Margin	-868.79%	52W Low	25.21%	ATR	0.16
Employees	98	Current Ratio	3.78	Sales Q/Q	-	Oper. Margin	-20606.38%	RSI (14)	36.91	Volatility	7.06% 10.99%
Optionable	Yes	Debt/Eq	0.65	EPS Q/Q	-	Profit Margin	-21217.79%	Rel Volume	0.70	Prev Close	1.45
Shortable	Yes	LT Debt/Eq	0.63	Earnings	Nov 13 AMC	Payout	-	Avg Volume	333.91K	Price	1.47
Recom	1.00	SMA20	-10.04%	SMA50	-27.05%	SMA200	-64.49%	Volume	233,510	Change	1.38%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-28-23	Initiated	Piper Sandler	Overweight	$10
Jun-15-23	Initiated	BTIG Research	Buy	$15
Apr-28-21	Initiated	Truist	Buy	$12
Oct-22-19	Initiated	Oppenheimer	Outperform	$9

Nov-15-23 04:05PM	Beyond Air To Participate in the 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire) +23.57%
Nov-14-23 10:00AM	Beyond Air, Inc. (NASDAQ:XAIR) Q2 2024 Earnings Call Transcript (Insider Monkey) -31.03%
Nov-13-23 04:05PM	Beyond Air Reports Financial Results for Second Quarter of Fiscal Year 2024 (GlobeNewswire)
Nov-03-23 12:00PM	Beyond Cancer Presents Positive First-in-Human Clinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting (GlobeNewswire) -6.91%
Oct-19-23 04:05PM	Beyond Air Schedules Second Fiscal Quarter 2024 Financial Results Conference Call and Webcast (GlobeNewswire)
04:05PM	Loading…
Oct-17-23 04:05PM	Beyond Air To Participate in the Truist Securities BioPharma Symposium (GlobeNewswire) +8.48%
07:30AM	Beyond Cancer Publishes Pre-Clinical Data in Cells Demonstrating that the Combination of Ultra-High Concentration Nitric Oxide (UNO) and Anti-mPD-1 Therapy Improves Tumor Regression Rates and Survival in Mice (GlobeNewswire)
Oct-16-23 07:30AM	Beyond Cancer Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) in Combination with Checkpoint Inhibitor Therapy During the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (GlobeNewswire)
07:00AM	Beyond Air Receives Innovative Technology Contract from Vizient for LungFit PH (GlobeNewswire)
Oct-04-23 07:30AM	Beyond Cancer Selected to Present Proffered Posters Discussing Data from the UNO Therapy Program at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (GlobeNewswire)
Oct-02-23 04:05PM	Beyond Air To Participate in the Roth MKM 2023 Healthcare Opportunities Conference (GlobeNewswire) -7.79%
Sep-27-23 09:00AM	Beyond Cancer to Present Initial Clinical Data for Ultra-High Concentration Nitric Oxide Therapy at the 2023 SITC Annual Meeting (GlobeNewswire)
Sep-18-23 04:05PM	Beyond Air® Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder (GlobeNewswire) -7.95%
Sep-07-23 07:30AM	Beyond Air® and Getz Healthcare Enter Strategic Collaboration to Commercialize LungFit PH in Asia-Pacific Region (GlobeNewswire)
Sep-06-23 07:00AM	Beyond Air® To Participate in the 2023 Cantor Global Healthcare Conference (GlobeNewswire)
04:05PM	Loading…
Aug-10-23 04:05PM	Beyond Air® Reports Financial Results for First Quarter of Fiscal Year 2024 (GlobeNewswire)
Aug-08-23 09:55AM	2 Strong Buy Penny Stocks That Could Rally All the Way to $10 (or More) (TipRanks) +13.35%
Aug-07-23 04:05PM	Beyond Air® Announces Positive Preclinical Data on Role of Nitric Oxide in Autism Spectrum Disorder (ASD) (GlobeNewswire)
Aug-01-23 04:05PM	Beyond Air® To Participate in BTIGs 2023 Virtual Biotechnology Conference (GlobeNewswire)
Jul-28-23 10:13AM	Block upgraded, Southwest downgraded: Wall Street's top analyst calls (The Fly) +7.12%
Jul-24-23 04:05PM	Beyond Air® Schedules First Fiscal Quarter 2024 Financial Results Conference Call and Webcast (GlobeNewswire) -6.11%
Jun-22-23 04:05PM	Beyond Air® Reports Financial Results for Fourth Quarter and Fiscal Year-End 2023 (GlobeNewswire)
Jun-15-23 04:10PM	Beyond Air® Secures up to $40 Million Debt Financing (GlobeNewswire)
04:05PM	Beyond Air® Licenses Commercial Rights to Selective Neuronal Nitric Oxide Synthase (nNOS) Inhibitors for the Treatment of Autism Spectrum Disorder from Hebrew University of Jerusalem (GlobeNewswire)
Jun-09-23 06:34AM	Daily Vickers Top Insider Picks for 06/09/2023 (Argus Research)
Jun-08-23 06:43AM	Daily Vickers Top Insider Picks for 06/08/2023 (Argus Research)
Jun-07-23 08:25AM	Daily Vickers Top Insider Picks for 06/07/2023 (Argus Research)
Jun-06-23 06:34AM	Daily Vickers Top Insider Picks for 06/06/2023 (Argus Research)
Jun-05-23 06:44AM	Daily Vickers Top Insider Picks for 06/05/2023 (Argus Research)
Jun-02-23 06:56AM	Daily Vickers Top Insider Picks for 06/02/2023 (Argus Research)
06:29AM	Loading…
Jun-01-23 06:29AM	Daily Vickers Top Insider Picks for 06/01/2023 (Argus Research)
May-31-23 06:40AM	Daily Vickers Top Insider Picks for 05/31/2023 (Argus Research)
May-30-23 06:50AM	Daily Vickers Top Insider Picks for 05/30/2023 (Argus Research)
May-26-23 06:59AM	Daily Vickers Top Insider Picks for 05/26/2023 (Argus Research)
May-25-23 06:38AM	Daily Vickers Top Insider Picks for 05/25/2023 (Argus Research)
May-24-23 06:43AM	Daily Vickers Top Insider Picks for 05/24/2023 (Argus Research)
May-23-23 06:33AM	Daily Vickers Top Insider Picks for 05/23/2023 (Argus Research)
May-22-23 07:49AM	Daily Vickers Top Insider Picks for 05/22/2023 (Argus Research)
May-19-23 07:03AM	Daily Vickers Top Insider Picks for 05/19/2023 (Argus Research)
May-18-23 06:39AM	Daily Vickers Top Insider Picks for 05/18/2023 (Argus Research)
May-17-23 06:35AM	Daily Vickers Top Insider Picks for 05/17/2023 (Argus Research)
May-16-23 04:05PM	Beyond Air® Schedules Fiscal Year End 2023 Financial Results Conference Call and Webcast (GlobeNewswire)
Apr-19-23 09:00AM	Beyond Cancer Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the American Association for Cancer Research (AACR) 2023 Annual Meeting (GlobeNewswire)
Mar-31-23 06:36AM	Daily Vickers Top Buyers & Sellers for 03/31/2023 (Argus Research)
Mar-23-23 04:05PM	Beyond Air® Appoints Jeff Myers, M.D. Ph.D. as Chief Medical Officer (GlobeNewswire) -5.84%
Mar-14-23 04:35PM	Beyond Cancer to Present Two Posters for Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2023 AACR Annual Meeting (GlobeNewswire) +6.59%
Mar-10-23 07:04AM	Daily Vickers Top Buyers & Sellers for 03/10/2023 (Argus Research)
Feb-22-23 07:00AM	Beyond Air® Announces Participation at Two Upcoming Investor Conferences in March 2023 (GlobeNewswire)
Feb-09-23 04:05PM	Beyond Air® Reports Financial Results for the Third Quarter of Fiscal Year 2023 (GlobeNewswire) -6.21%
Jan-30-23 07:00AM	Beyond Cancer® Appoints Gavin Choy, PharmD as Chief Operating Officer (GlobeNewswire)
Jan-24-23 04:05PM	Beyond Cancer® Announces Sponsored Research Agreement with Stanford and Appointment of Frederick M. Dirbas, MD and Mark D. Pegram, MD to Scientific Advisory Board (GlobeNewswire)
Jan-17-23 04:05PM	Beyond Air® Schedules Third Fiscal Quarter 2023 Financial Results Conference Call and Webcast (GlobeNewswire)
Dec-13-22 09:25AM	Beyond Cancer® Publishes Pre-Clinical Data in Cancer Cell International Demonstrating Its Tumor Ablation Method Utilizing Ultra-High Concentration Nitric Oxide (UNO) Induced a Systemic Response that Prevents Metastases (GlobeNewswire) +9.26%
Nov-17-22 04:05PM	Beyond Air® To Participate in Pipers 34th Annual Healthcare Conference (GlobeNewswire) -6.08%
Nov-10-22 09:00AM	Beyond Cancer Presents Promising New In Vivo Data Showing Ultra-High Concentration Nitric Oxide Therapy (UNO) in Combination with Anti-PD-1 During the Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting (GlobeNewswire)
Nov-08-22 04:05PM	Beyond Air® Reports Financial Results for the Second Quarter of Fiscal Year 2023 (GlobeNewswire)
Oct-24-22 07:30AM	Beyond Air® Announces Positive Data for Inhaled Nitric Oxide (NO) to Treat COVID-19 with LungFit® PRO in a Poster Presentation at IDWeek 2022 (GlobeNewswire)
Oct-20-22 04:05PM	Beyond Air® Schedules Second Fiscal Quarter 2023 Financial Results Conference Call and Webcast (GlobeNewswire) +7.55%
Oct-17-22 04:05PM	Beyond Air® Announces Positive Data from At-Home Pilot Study in Patients with Refractory NTM Lung Infection Treated with (NO) using the LungFit® GO at the CHEST Annual Meeting 2022 (GlobeNewswire)
Oct-05-22 08:00AM	Beyond Cancer to Present Pre-Clinical Data for Ultra-High Concentration Nitric Oxide Therapy at the 2022 SITC Annual Meeting (GlobeNewswire)
Oct-03-22 07:30AM	Beyond Air® Announces that Annals of the American Thoracic Society Published a Review of the Third Pilot Study of High Dose Nitric Oxide for Bronchiolitis (GlobeNewswire)
Sep-16-22 04:05PM	Beyond Air® To Participate in Three Upcoming Investor Conferences (GlobeNewswire)
Aug-23-22 08:00AM	Beyond Air® Affiliate Beyond Cancer Doses Initial Patient in First-in-Human Phase 1 Study of Ultra-High Concentration Nitric Oxide Therapy at Tel Aviv Sourasky Medical Center (Ichilov) (GlobeNewswire) +10.12%
Aug-11-22 04:05PM	Beyond Air® Reports Financial Results for the First Quarter of Fiscal Year 2023 (GlobeNewswire)
Jul-27-22 04:05PM	Beyond Air® Schedules First Fiscal Quarter 2023 Financial Results Conference Call and Webcast (GlobeNewswire)
Jun-28-22 04:10PM	Beyond Air® Reports Financial Results for Fourth Fiscal Quarter and Year-End 2022 (GlobeNewswire) -7.81%
04:05PM	Beyond Airs LungFit® PH Receives FDA Approval to Treat Term and Near-Term Neonates with Hypoxic Respiratory Failure (GlobeNewswire)
Jun-14-22 04:30PM	Beyond Air® Announces Fiscal Year End 2022 Financial Results Conference Call and Webcast Moved to Tuesday, June 28th (GlobeNewswire)
Jun-01-22 07:00AM	Beyond Cancer Announces the Appointment of Jedidiah Monson, M.D. to Chief Medical Officer (GlobeNewswire)
May-17-22 04:05PM	Beyond Air® Presents Positive Study Update from the At-Home LungFit® GO Pilot Study for Nontuberculous Mycobacterial Lung Disease at the American Thoracic Society International Conference 2022 (GlobeNewswire) +7.84%
07:00AM	Beyond Cancer, Ltd. Appoints Susan Howell Jones, CPA as Chief Financial Officer (GlobeNewswire)
May-16-22 07:05AM	Beyond Air® Schedules Fiscal Year 2022 Financial Results Conference Call and Webcast (GlobeNewswire)
May-06-22 06:29AM	Loss-Making Beyond Air, Inc. (NASDAQ:XAIR) Expected To Breakeven In The Medium-Term (Simply Wall St.)
Apr-25-22 04:05PM	Beyond Air® Reports Positive Long-Term Safety Data for High Concentration Inhaled Nitric Oxide in Bronchiolitis at the Pediatric Academic Societies Meeting 2022 (GlobeNewswire) +12.02%
07:00AM	Beyond Air® Presents Positive Safety and Efficacy Data for Inhaled Nitric Oxide to Treat COVID-19 at ECCMID 2022 (GlobeNewswire)
Apr-18-22 07:00AM	Beyond Air® to Participate in Three Upcoming Medical Conferences (GlobeNewswire)
Apr-11-22 07:00AM	Beyond Cancer Announces New Preclinical Data Presented at American Association for Cancer Research (AACR) Showing Ultra-High Concentration Nitric Oxide Therapy Anti-Tumor Effect (GlobeNewswire) -7.95%
Mar-08-22 04:35PM	Beyond Cancer to Present Two Abstracts for Ultra-High Concentration Nitric Oxide Therapy at the 2022 AACR Annual Meeting (GlobeNewswire)
Feb-22-22 04:52AM	Beyond Air (NASDAQ:XAIR) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Feb-10-22 04:05PM	Beyond Air® Reports Financial Results for the Third Quarter of Fiscal Year 2022 (GlobeNewswire)
Feb-08-22 08:00AM	Beyond Air® Announces Participation at Upcoming Investor Conferences in March 2022 (GlobeNewswire)
Feb-03-22 04:05PM	Beyond Air® Announces Two Appointments to Beyond Cancer Board of Directors (GlobeNewswire)
Jan-27-22 08:00AM	Beyond Air® Schedules Third Fiscal Quarter 2022 Financial Results Conference Call and Webcast (GlobeNewswire) -5.94%
Dec-14-21 09:15AM	Beyond Air Inc (XAIR) CEO and Chairman of the Board Steven A. Lisi Bought $341,200 of Shares (GuruFocus.com) +9.35%
Dec-10-21 09:14AM	Implied Volatility Surging for Beyond Air (XAIR) Stock Options (Zacks)
Dec-09-21 08:30AM	Beyond Air® Provides Regulatory Update for LungFit® PH (GlobeNewswire) -20.45%
05:56AM	Beyond Air Slides After LungFit Launch Delay (Investing.com)
Dec-01-21 08:00AM	Beyond Air® Expands Leadership Team with the Appointment of Dr. Andrew Colin to Chief Medical Officer (GlobeNewswire)
Nov-18-21 04:05PM	Beyond Air® Announces $30 Million of Committed Capital in Previously Reported Beyond Cancer Private Placement (GlobeNewswire) -6.49%
Nov-11-21 04:05PM	Beyond Air® Reports Financial Results for the Second Quarter of Fiscal Year 2022 (GlobeNewswire)
Nov-04-21 03:01PM	Beyond Air, Inc. (XAIR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks) -9.44%
07:30AM	Beyond Air® Announces Formation of Beyond Cancer, a New Private Company Dedicated to Oncology Utilizing Ultra-High Concentration Nitric Oxide to Treat Solid Tumors (GlobeNewswire)
Nov-02-21 08:00AM	Beyond Air® to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference (GlobeNewswire)
Oct-25-21 08:00AM	Beyond Air® Schedules Second Fiscal Quarter 2022 Financial Results Conference Call and Webcast (GlobeNewswire) +5.37%
Oct-20-21 08:00AM	Beyond Air® Reports Positive Interim Results for LungFit® GO Pilot Study Using High Concentration Inhaled Nitric Oxide Self-Administered, At-Home for Nontuberculous Mycobacterial Lung Disease (GlobeNewswire)
Sep-21-21 04:30PM	Beyond Air® Provides Global Regulatory Update for LungFit® PH (GlobeNewswire) +6.91%
Sep-14-21 07:30AM	Beyond Air® to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (GlobeNewswire)
Aug-25-21 03:55PM	3 Strong Buy Stocks Showing Monster Growth (TipRanks) +7.97%
Aug-20-21 04:15PM	Beyond Air® Announces CFO Transition (GlobeNewswire) -5.20%
Aug-10-21 04:05PM	Beyond Air® Reports Financial Results for the First Quarter of Fiscal Year 2022 (GlobeNewswire)

Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in developing a platform for nitric oxide generators and delivery systems. It operates through the Beyond Air and Beyond Cancer segments. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gaul Michael A.	Chief Operating Officer	Nov 16	Buy	1.77	10,000	17,700	88,150	Nov 17 04:15 PM
Carey Robert	Director	Aug 28	Buy	2.69	250,000	673,750	1,225,160	Aug 29 04:10 PM
Carey Robert	Director	Aug 21	Buy	2.76	75,050	207,453	975,160	Aug 22 04:10 PM
Carey Robert	Director	Aug 18	Buy	2.64	13,614	35,940	900,110	Aug 22 04:10 PM
Gaul Michael A.	Chief Operating Officer	Jun 30	Buy	4.51	5,000	22,550	78,150	Jul 05 04:05 PM
Forbes William P	Director	Mar 31	Buy	6.67	5,000	33,350	14,855	Apr 03 04:15 PM
Carey Robert	Director	Mar 30	Buy	6.45	10,000	64,500	886,496	Mar 30 06:39 PM
Carey Robert	Director	Mar 29	Buy	6.30	10,000	63,000	876,496	Mar 30 06:39 PM
Lee Yoori	Director	Mar 28	Buy	6.34	3,115	19,749	12,654	Mar 29 05:47 PM
Gaul Michael A.	Chief Operating Officer	Mar 24	Buy	6.15	1,000	6,150	73,150	Mar 27 04:05 PM
BENTSUR RON	Director	Mar 20	Buy	6.48	2,300	14,904	144,736	Mar 21 04:05 PM
Lisi Steven A.	CEO and Chairman of the Board	Mar 17	Buy	6.46	10,000	64,600	1,458,696	Mar 21 04:05 PM
Forbes William P	Director	Mar 17	Buy	6.46	5,000	32,300	9,855	Mar 20 04:05 PM
Lucera Erick	Director	Mar 16	Buy	6.82	2,000	13,634	4,342	Mar 20 04:10 PM
Carey Robert	Director	Mar 14	Buy	6.85	10,000	68,500	866,496	Mar 15 04:05 PM
Carey Robert	Director	Mar 13	Buy	6.15	4,173	25,664	856,496	Mar 15 04:05 PM
Avniel Amir	Chief Business Officer	Mar 13	Buy	6.40	1,000	6,400	457,027	Mar 15 04:05 PM
Carey Robert	Director	Mar 08	Buy	5.95	10,000	59,500	852,323	Mar 09 04:05 PM
Lisi Steven A.	CEO and Chairman of the Board	Mar 08	Buy	5.89	5,000	29,435	1,447,849	Mar 09 04:05 PM
Lisi Steven A.	CEO and Chairman of the Board	Mar 07	Buy	5.98	45,000	268,920	1,442,849	Mar 09 04:05 PM
Gaul Michael A.	Chief Operating Officer	Mar 07	Buy	5.86	8,000	46,880	72,150	Mar 09 04:05 PM
Lisi Steven A.	CEO and Chairman of the Board	Feb 16	Sale	6.10	48,596	296,436	1,397,849	Feb 17 04:30 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

NVCT

Nuvectis Pharma Inc

XAIR

Beyond Air Inc

Upgrade your FINVIZ experience